Grants

Grants & Other Sponsored Projects

 

We're working to update the sponsored projects information that appears on this page. Please check back!

Title Principal Investigator Unitsort descending Sponsor Name
Phase I/II Trial of Vorinostat with R-CHOP in Patients with Advanced Stage DLBCL
Persky,Daniel O
Cancer Center Division
The Hope Foundation
An open label, multi-center, phase 3 study with corresponding blinded image to determine the efficacy and safety of a single intravenous injection ..
Kuo,Phillip H
Cancer Center Division
Bayer Healthcare Pharmaceuticals Incorportated
Networks Among Tribal Organizations for Clean Air Policies (NATO CAP)
Leischow,Scott J
Cancer Center Division
National Cancer Institute
Development of folic acid derivatives for skin protection
Gandolfi,A Jay
Cancer Center Division
Niadyne, Incorporated
Southwest Oncology Group Operations Office Grant
Krouse,Robert S
Cancer Center Division
University of Michigan
Equipment and Training Grant
Iannone,Maria E
Cancer Center Division
The Hemophilia Alliance Foundation
Molecular mechanisms of centrosome amplification in cancer cells
Rogers,Gregory C
Cancer Center Division
Arizona Biomedical Research Commission
USC Consortium: Colon Cancer Family Registry
Lance,Michael P
Cancer Center Division
University of Southern California
MK-3475 Randomized, Phase II study of MK-3475 versus Chemotherapy
Cranmer,Lee D
Cancer Center Division
Merck and Company
Patient and Physician Survey for DAT Scan
Kuo,Phillip H
Cancer Center Division
General Electric Healthcare
A Phase 1/2 Study to Assess the Safety and Efficacy of Lorvotuzumab Mertansine (IMGN901) in Combination with Carboplatin/Etoposide in Patients with ..
Garland,Linda L
Cancer Center Division
ImmunoGen Incorporated
Physical Activity Forms and Processing Support
Hamilton,Lynn A
Cancer Center Division
Science Applications International Corporation
A Phase II Randomized, Double-blind, Placebo-Controlled Clinical Trial to Study the Efficacy and Safety of Bicalutamide with or without Deforolimus...
Ahmann,Frederick R
Cancer Center Division
Merck and Company
Southwest Oncology Group Operations Office Grant
Miller,Thomas P
Cancer Center Division
University of Michigan
Phase 1/2 open-label study of the safety & efficacy of PD0332991 in combination w/ bortezomib & dexamethasone in patients w/refractory multiple myeloa
Yeager,Andrew M
Cancer Center Division
INC Research, Incorporated
ML27763 "An open-Label Multicenter Phase II Study of Continuous Oral Vemurafenib in Patients with Metastatic Melanoma and BRAF
Hersh,Evan M
Cancer Center Division
Genetech, Incorporated
Phase III Colon Cancer Prevention Trial
Gerner,Eugene W
Cancer Center Division
University of California, Irvine
A...Study Comparing the Combination of the BRAF Inhibitor, Dabrafenib and the MEK Inhibitor, Trametinib to Dabrafenib and Placebo as First-Line ...
Cranmer,Lee D
Cancer Center Division
Glaxosmithkline
...Phase IIIa Treatment Investigation on...MAX-002 Suppository versus Placebo and Active Medicine in Mild to Moderate Ulcerative Proctitis
Lance,Michael P
Cancer Center Division
Axcan Pharma
Vida! The Fifth Annual Mujer Latina Breast Cancer Conference
Lopez,Ana Maria
Cancer Center Division
Susan G. Komen Breast Cancer Foundation
A-LONG: An Open-label, Multicenter Evaluation of the Safety, Pharmacokinetics, and Efficacy of Recombinant Factor VIII Fc Fusion Protein ...
Stopeck,Alison T
Cancer Center Division
Biogen Idec, Incorporated
A Multicenter Treatment Protocol for Expanded Access Use of Ipilimumab (BMS-734016) in Subjects with Unresectable Stage III or Stahe VI Melanoma
Hersh,Evan M
Cancer Center Division
Bristol-Myers Squibb
Exploration of the use of [124I]FIAU Positron Emission Tomography-Computed Tomography Scanning in Diagnosing Osteomyelitis in Patients with Diabetic F
Kuo,Phillip H
Cancer Center Division
Covance, Incorporated
A...Study Evaluating the Efficacy of Doxorubicin With or Without a Human Anti-PDGFRa Monoclonal Antibody (IMC-3G3) in the Treatment of Advanced ...
Cranmer,Lee D
Cancer Center Division
ImClone Systems Corporation
A Two-Cohort, Open-Label, Multicenter Phase II Trial Assessing the Efficacy and Safety of Pertuzumab Given in Combination with Tratuzumab and Vinor...
Stopeck,Alison T
Cancer Center Division
Genetech, Incorporated
Regional Hemophilia Network-Mountain States
Stopeck,Alison T
Cancer Center Division
Oregon Health and Science University
Development of an Automated in situ Test to Perform Molecular Sub-classification of Prostate Cancer in Standard Prostate Biopsies
Stratton,Steven P
Cancer Center Division
Ventana Medical Systems, Inc.
Dynamic Phase Imaging Interference 4D Microscope System
Rouse,Andrew R
Cancer Center Division
4D Technology Corporation
Equipment and Training Grant
Iannone,Maria E
Cancer Center Division
The Hemophilia Alliance Foundation
Evaluation of a Novel Circulating Microvesicle-Based Multi-analyte Assay for the Detection of Prostate Cancer in Men with Elevated Risk for ...
Sokoloff,Mitchell H
Cancer Center Division
Caris Life Sciences

Pages

UA@Work is produced by University Communications

888 N. Euclid Ave., Ste. 413 (or) 
P.O. Box 210158, Tucson, AZ 85721

T 520.621.1877  F 520.626.4121

Feedback

2018 © The Arizona Board of Regents on behalf of the University of Arizona